Should I Use a Committee Letter or Individual LORs for Med School?

Use a committee letter if your school offers it and you can get a strong one on time; most med schools expect to see it from institutions that provide it, and choosing individual letters instead can raise an avoidable “why” question. Start by confirming your prehealth office’s process, timeline, and what their packet includes, then ask directly how they handle applicants they can’t strongly endorse. If the committee system will be lukewarm, delayed, or administratively messy, pivot to individual LORs and treat that choice as intentional: secure two science faculty, one non-science (if your target schools prefer it), and one clinical/research supervisor who can speak to impact and reliability, then use AMCAS letter entries to keep everything clean and clearly labeled. The simplest rule is this: send the strongest, clearest endorsement package you can control, with no missing pieces and no awkward gaps.

What most applicants don’t realize is that “committee vs individual” isn’t a prestige decision, it’s a signal-management decision. A committee letter helps when it adds synthesis, context for your institution, and a credible summary of readiness; it hurts when it becomes a vague umbrella that washes out your best evidence. Do a quick inventory of your likely writers and ask yourself: who can name specific behaviors, outcomes, and moments that would still sound compelling if read aloud to a stranger? If you have three or four people who can do that, individual letters can be more vivid than a committee packet. If your best advocates are inside the prehealth system and the committee will amplify them, take the structure and let it work for you. Either way, your job is to make the reader’s confidence feel inevitable, not negotiable.